| Drug Name |
Omeprazole magnesium |
| Drug ID |
BADD_D01615 |
| Description |
Originally approved by the FDA in 1989, omeprazole is a _proton-pump inhibitor_, used to treat gastric acid-related disorders. These disorders may include gastroesophageal reflux disease (GERD), peptic ulcer disease, and other diseases characterized by the oversecretion of gastric acid. This drug was the first clinical useful drug in its class, and its approval was followed by the formulation of many other proton pump inhibitor drugs [A174232]. Omeprazole is generally effective and well-tolerated, promoting its popular use in children and adults [FDA label]. |
| Indications and Usage |
Omeprazole is indicated for the treatment of duodenal ulcers, benign gastric ulcers, gastroesophageal reflux disease (GERD), heartburn and other symptoms associated with GERD, erosive esophagitis, and long-term treatment of pathological hypersecretory conditions like Zollinger-Ellison syndrome, multiple endocrine adenomas, and systemic mastocytosis. |
| Marketing Status |
Prescription; OTC; Discontinued |
| ATC Code |
A02BC01 |
| DrugBank ID |
DB00338
|
| KEGG ID |
D05259
|
| MeSH ID |
D009853
|
| PubChem ID |
5311083
|
| TTD Drug ID |
D01XNB
|
| NDC Product Code |
41250-064; 0363-0042; 0186-0742; 0363-9980; 37000-459; 70518-2167; 63868-177; 62207-006; 66174-0072; 65862-531; 55111-397; 17228-0750; 69842-027; 0186-0743; 59726-737; 0186-0606; 21130-398; 70515-610; 59726-297; 37000-455; 49711-0117; 55315-367; 58175-0559; 55111-049; 42765-017; 43598-813; 43598-408; 57896-759; 53943-520; 68016-760; 70515-625; 37808-006; 55319-916; 64374-009; 11673-948; 17228-0740; 70000-0232 |
| Synonyms |
Omeprazole | Prilosec | Omeprazole Sodium | Sodium, Omeprazole | H 168-68 | H 168 68 | H 16868 | Omeprazole Magnesium | Magnesium, Omeprazole |
